rs1135128

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006371.5(CRTAP):​c.1044G>A​(p.Ser348Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 1,612,154 control chromosomes in the GnomAD database, including 136,984 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 10571 hom., cov: 32)
Exomes 𝑓: 0.41 ( 126413 hom. )

Consequence

CRTAP
NM_006371.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.88

Publications

23 publications found
Variant links:
Genes affected
CRTAP (HGNC:2379): (cartilage associated protein) The protein encoded by this gene is similar to the chicken and mouse CRTAP genes. The encoded protein is a scaffolding protein that may influence the activity of at least one member of the cytohesin/ARNO family in response to specific cellular stimuli. Defects in this gene are associated with osteogenesis imperfecta, a connective tissue disorder characterized by bone fragility and low bone mass. [provided by RefSeq, Jul 2008]
CRTAP Gene-Disease associations (from GenCC):
  • osteogenesis imperfecta type 7
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 3-33132676-G-A is Benign according to our data. Variant chr3-33132676-G-A is described in ClinVar as Benign. ClinVar VariationId is 259969.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.88 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.43 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRTAPNM_006371.5 linkc.1044G>A p.Ser348Ser synonymous_variant Exon 5 of 7 ENST00000320954.11 NP_006362.1
CRTAPNM_001393363.1 linkc.1044G>A p.Ser348Ser synonymous_variant Exon 5 of 6 NP_001380292.1
CRTAPNM_001393364.1 linkc.915G>A p.Ser305Ser synonymous_variant Exon 4 of 6 NP_001380293.1
CRTAPNM_001393365.1 linkc.894G>A p.Ser298Ser synonymous_variant Exon 4 of 6 NP_001380294.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRTAPENST00000320954.11 linkc.1044G>A p.Ser348Ser synonymous_variant Exon 5 of 7 1 NM_006371.5 ENSP00000323696.5
CRTAPENST00000449224.1 linkc.915G>A p.Ser305Ser synonymous_variant Exon 4 of 6 2 ENSP00000409997.1
CRTAPENST00000485310.1 linkn.*76G>A downstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.361
AC:
54816
AN:
151946
Hom.:
10573
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.261
Gnomad AMI
AF:
0.372
Gnomad AMR
AF:
0.305
Gnomad ASJ
AF:
0.525
Gnomad EAS
AF:
0.137
Gnomad SAS
AF:
0.381
Gnomad FIN
AF:
0.390
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.435
Gnomad OTH
AF:
0.409
GnomAD2 exomes
AF:
0.369
AC:
92871
AN:
251470
AF XY:
0.383
show subpopulations
Gnomad AFR exome
AF:
0.264
Gnomad AMR exome
AF:
0.208
Gnomad ASJ exome
AF:
0.536
Gnomad EAS exome
AF:
0.135
Gnomad FIN exome
AF:
0.395
Gnomad NFE exome
AF:
0.438
Gnomad OTH exome
AF:
0.399
GnomAD4 exome
AF:
0.409
AC:
597731
AN:
1460090
Hom.:
126413
Cov.:
41
AF XY:
0.412
AC XY:
299267
AN XY:
726452
show subpopulations
African (AFR)
AF:
0.264
AC:
8814
AN:
33446
American (AMR)
AF:
0.219
AC:
9802
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.532
AC:
13904
AN:
26118
East Asian (EAS)
AF:
0.121
AC:
4785
AN:
39688
South Asian (SAS)
AF:
0.413
AC:
35617
AN:
86206
European-Finnish (FIN)
AF:
0.397
AC:
21199
AN:
53402
Middle Eastern (MID)
AF:
0.509
AC:
2916
AN:
5728
European-Non Finnish (NFE)
AF:
0.429
AC:
476362
AN:
1110474
Other (OTH)
AF:
0.403
AC:
24332
AN:
60308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
18366
36732
55098
73464
91830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14234
28468
42702
56936
71170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.360
AC:
54818
AN:
152064
Hom.:
10571
Cov.:
32
AF XY:
0.358
AC XY:
26596
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.261
AC:
10814
AN:
41476
American (AMR)
AF:
0.304
AC:
4647
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.525
AC:
1822
AN:
3468
East Asian (EAS)
AF:
0.137
AC:
712
AN:
5182
South Asian (SAS)
AF:
0.380
AC:
1834
AN:
4826
European-Finnish (FIN)
AF:
0.390
AC:
4125
AN:
10564
Middle Eastern (MID)
AF:
0.466
AC:
137
AN:
294
European-Non Finnish (NFE)
AF:
0.435
AC:
29531
AN:
67948
Other (OTH)
AF:
0.406
AC:
859
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1762
3523
5285
7046
8808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.409
Hom.:
11937
Bravo
AF:
0.347
Asia WGS
AF:
0.242
AC:
847
AN:
3478
EpiCase
AF:
0.439
EpiControl
AF:
0.453

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Osteogenesis imperfecta type 7 Benign:5
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Mar 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.076
DANN
Benign
0.40
PhyloP100
-1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1135128; hg19: chr3-33174168; COSMIC: COSV58013914; COSMIC: COSV58013914; API